Ex parte SINGH et al. - Page 31




          Appeal No. 95-0865                                                           
          Application 08/08/007,950                                                    

          Zahler describes the reaction of purines with cyclobutanes.                  
          Zahler specifically describes the reaction of (1) a cyclobutane              
          Compound 2 (page 9) having a leaving group which may be, inter               
          alia, mesyl, triflyl or nosyl (page 9, lines 24-25) with (2) a               
          purine Compound 3 (also page 9) to make (3) a 9-disubstituted-               
          purine (Compound 4) using either potassium carbonate, sodium                 
          hydride or potassium hydride (page 9, line 43) or Compound 3 in              
          its tetraalkylammonium salt form (page 10, lines 19-21).  Zahler             
          also describes making a 9-disubstituted cyclobutane-6-chloro-2-              
          amino-purine (Compound 6--page 11) "under conditions analogous to            
          those used in making the preparation of compound 4" (page 11,                
          lines 12-13).                                                                
               In light of our discussion above, a person having ordinary              
          skill in the art would have found it obvious to react applicants'            
          purine in its tetraalkylammonium salt form with a bis                        
          (2,3-protected hydroxymethyl) cyclobutane having an X group which            
          is a perfluoroalkane sulfonyloxy group, such as triflyl.  It                 
          follows that the subject matter of claim 6 includes subject                  
          matter which would have been obvious within the meaning of                   
          35 U.S.C. § 103.                                                             

                         d.   Claim 7                                                  



                                        - 31 -                                         





Page:  Previous  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  Next 

Last modified: November 3, 2007